Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any hereditary ataxia in which the cause of the disease is a mutation in the RNF170 gene.
Features include always present findings: Hyporeflexia, Gait ataxia, Sensory ataxia, and Distal sensory impairment of all modalities; and common findings: Impaired distal proprioception, Difficulty walking (gait disturbance), Dysarthria, and Dysesthesia and others. 17 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Hyporeflexia, Babinski sign, Difficulty walking (gait disturbance) |
RNF170 function has not been fully characterized.
Autosomal dominant sensory ataxia 1 is associated with mutations in the RNF170 gene on chromosome 8.
Genetic testing for RNF170 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features, 9 common features.
No clinical trials have been registered for autosomal dominant sensory ataxia 1.
120 publications have been identified in PubMed for autosomal dominant sensory ataxia 1. Kisho has analyzed 88 by research type. Research spans Basic Science / Preclinical (28%), Review / Meta-Analysis (25%), and Case Report / Case Series (24%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 25 | 28% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 9:47 AM UTC
Online Mendelian Inheritance in Man
Eyes | 1 | Abnormal vestibulo-ocular reflex |
Ears | 1 | Abnormal vestibulo-ocular reflex |
Muscles | 1 | Frequent falls |
Research summaries |
22 |
25% |
Patient case studies | 21 | 24% |
Disease patterns and progression | 13 | 15% |
Clinical study results | 5 | 6% |
New treatment approaches | 2 | 2% |
Bermejo-Guerrero L (2026). [PMID: 41822038](https://pubmed.ncbi.nlm.nih.gov/41822038/). *Neurol Genet*. [Basic Science / Preclinical]
Paulino LA (2026). [PMID: 41395683](https://pubmed.ncbi.nlm.nih.gov/41395683/). *Expert Rev Neurother*. [Review / Meta-Analysis]
de Jesus Araujo Dias A (2026). [PMID: 42168446](https://pubmed.ncbi.nlm.nih.gov/42168446/). *J Neurol*. [Basic Science / Preclinical]
Ding S (2026). [PMID: 40396313](https://pubmed.ncbi.nlm.nih.gov/40396313/). *Current neuropharmacology*. [Review / Meta-Analysis]
Hines TJ (2026). [PMID: 41889878](https://pubmed.ncbi.nlm.nih.gov/41889878/). *bioRxiv*. [Basic Science / Preclinical]
Reniers CJM (2026). [PMID: 41952467](https://pubmed.ncbi.nlm.nih.gov/41952467/). *Mov Disord*. [Epidemiology / Natural History]
Koutsis G (2026). [PMID: 41277402](https://pubmed.ncbi.nlm.nih.gov/41277402/). *Clin Genet*. [Epidemiology / Natural History]
Rodrigues L (2026). [PMID: 41866445](https://pubmed.ncbi.nlm.nih.gov/41866445/). *Cerebellum*. [Epidemiology / Natural History]
van Prooije TH (2026). [PMID: 41504274](https://pubmed.ncbi.nlm.nih.gov/41504274/). *Movement disorders : official journal of the Movement Disorder Society*. [Epidemiology / Natural History]
Attar A (2026). [PMID: 41636949](https://pubmed.ncbi.nlm.nih.gov/41636949/). *Cerebellum*. [Review / Meta-Analysis]